Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3217837
Max Phase: Preclinical
Molecular Formula: C35H40N6O4
Molecular Weight: 608.74
Molecule Type: Protein
Associated Items:
ID: ALA3217837
Max Phase: Preclinical
Molecular Formula: C35H40N6O4
Molecular Weight: 608.74
Molecule Type: Protein
Associated Items:
Canonical SMILES: NCCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C35H40N6O4/c36-17-9-8-14-28(37)33(42)40-31(18-24-20-38-29-15-6-4-12-26(24)29)34(43)41-32(35(44)45-22-23-10-2-1-3-11-23)19-25-21-39-30-16-7-5-13-27(25)30/h1-7,10-13,15-16,20-21,28,31-32,38-39H,8-9,14,17-19,22,36-37H2,(H,40,42)(H,41,43)/t28-,31-,32-/m0/s1
Standard InChI Key: IHYQSMPYDOHXJN-MHDHXZMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 608.74 | Molecular Weight (Monoisotopic): 608.3111 | AlogP: 3.60 | #Rotatable Bonds: 15 |
Polar Surface Area: 168.12 | Molecular Species: BASE | HBA: 6 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.22 | CX Basic pKa: 10.20 | CX LogP: 3.60 | CX LogD: 0.18 |
Aromatic Rings: 5 | Heavy Atoms: 45 | QED Weighted: 0.08 | Np Likeness Score: 0.10 |
1. Liu L, Wei L, Yang Y, Zhao M, Zhang X, Zheng M, Wang Y, Peng S. (2011) A class of novel AA-Trp-Trp-OBzl: synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and intercalation mechanism, 2 (2): [10.1039/C0MD00208A] |
Source(1):